SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-021420
Filing Date
2024-02-27
Accepted
2024-02-27 17:21:23
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 vktx-2024-02-29-424b5_v2.htm 424B5 677922
2 GRAPHIC img60149894_0.jpg GRAPHIC 13142
3 GRAPHIC img60149894_1.jpg GRAPHIC 63809
4 GRAPHIC img60149894_2.jpg GRAPHIC 11923
5 GRAPHIC img60149894_3.jpg GRAPHIC 4119
  Complete submission text file 0000950170-24-021420.txt   807556
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-273460 | Film No.: 24688616
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)